Identification of novel loci associated with mycobacterial isoniazid resistance

Tuberculosis
Gopinath ViswanathanTirumalai R Raghunand

Abstract

Despite the known association of several genes to clinical Isoniazid (INH) resistance, its molecular basis remains unknown in ~16% of clinical isolates of Mycobacterium tuberculosis (M. tb). While screening a set of Mycobacterium smegmatis (M. smegmatis) transposon mutants with altered colony morphology for differential susceptibility to INH, we found six resistant mutants and mapped their transposon insertion sites. The disrupted genes in six INH resistant mutants were homologs of M. tb ctaE, rplY, tatA, csd and tatB with one insertion mapping to the promoter region of M. smegmatis ctaE. MIC measurements indicated a wide spectrum of INH resistance in these mutants, with complementation analyses of four selected mutants with the cognate M. smegmatis genes and their M. tb homologs confirming the association of the disrupted genes with INH resistance. Our discovery of novel genes associated with INH resistance could lead to the identification of novel INH resistance mechanisms and possibly new diagnostic modalities as well.

References

Mar 17, 2001·Molecular Microbiology·T C ZahrtV Deretic
Jun 16, 2001·Antimicrobial Agents and Chemotherapy·A S LeeS Y Wong
May 31, 2003·Proceedings of the National Academy of Sciences of the United States of America·Gyanu LamichhaneWilliam R Bishai
Jan 28, 2005·Antimicrobial Agents and Chemotherapy·Catherine VilchèzeWilliam R Jacobs
Nov 24, 2007·Annual Review of Microbiology·Catherine Vilchèze, William R Jacobs
Jun 18, 2010·The Journal of Biological Chemistry·Ben WisemanPeter C Loewen
Oct 26, 2011·The Journal of Infectious Diseases·David A J Moore, N Sarita Shah

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease
B HeymS Cole
Trends in Microbiology
Jaya Sivaswami Tyagi, Deepak Sharma
© 2022 Meta ULC. All rights reserved